Evidence map›Paper›PMID 39496788›Full record

ArticleScientific reports2024

The characterization of an IncN-IncR fusion plasmid co-harboring bla

Lei Fang, Yanhao Shen, Ruyan Chen, Chenyu Li, Ruishan Liu, Yuanyuan Jia, Saiqi Qi, Xiaobing Guo

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Molecular Insights into Carbapenem Resistance inInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Co-harboringChina CDC weekly · 2025
    Article
  4. Article
  5. Molecular Epidemiological Characteristics ofInfection and drug resistance · 2025
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lei Fang *Department of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Yanhao Shen *Department of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Ruyan ChenDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Chenyu LiDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Ruishan LiuCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Yuanyuan JiaDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Saiqi QiDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Xiaobing GuoDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. gxbing928@zzu.edu.cn.

Funding

Henan Provincial Science and Technology Research Project,China 232102310176
6 · The paper itself

Abstract

Plasmids, as important genetic elements apart from chromosomes, often carry multiple resistance genes and various mobile genetic elements, enabling them to acquire more exogenous genes and confer additional resistance phenotypes to bacteria. Various carbapenem resistance genes are often located on IncN plasmids, and several reports have linked fusion plasmids to IncN plasmids. Therefore, this study aims to explore the emergence, molecular structure characteristics, and resistance features mediated by IncN fusion plasmids carrying multiple carbapenem resistance genes. In this study, species identification was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS). Polymerase chain reaction (PCR) was employed to detect the presence of carbapenem resistance genes in the strains. PCR-based replicon typing (PBRT) was used to identify IncN plasmids. Plasmids were analyzed through S1-nuclease pulsed-field gel electrophoresis (S1-PFGE), Southern blotting, conjugation experiments, and stability tests. Whole-genome sequencing (WGS) and antimicrobial susceptibility testing (AST) were conducted to characterize the target strains. Four strains containing IncN plasmids were identified: two Klebsiella pneumoniae, one Escherichia coli, and one Enterobacter cloacae, all harboring carbapenem resistance genes. Among them, two IncN plasmids (pFAHZZU7605-KPC-IMP and pFAHZZU7865-IMP) contained blaIMP-4 and exhibited similar molecular structure characteristics. Notably, the pFAHZZU7605-KPC-IMP plasmid harbored both IncN and IncR replicons. We hypothesize that the pFAHZZU7605-KPC-IMP fusion plasmid resulted from the recombination of a pFAHZZU7865-IMP-like plasmid and an IncR-like plasmid. Further analysis of the plasmid's genetic elements revealed that insertion sequences ISKpn19 and ISKpn27 played crucial roles in the plasmid recombination and fusion process. In clinical settings, plasmids carrying different resistance genes can undergo fusion, mediated by genetic elements, thereby expanding the resistance spectrum of host bacteria. Hence, it is essential to enhance the monitoring and research of transposable elements to control the spread of multidrug-resistant bacteria.

Indexed as

beta-LactamasesKlebsiella pneumoniaePlasmidsAnti-Bacterial AgentsBacterial ProteinsCarbapenemsDrug Resistance, Multiple, BacterialHumansKlebsiella InfectionsMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase IMP-4beta-LactamasesCarbapenemsbla IMP−4bla KPC−2Carbapenem-resistant Klebsiella pneumoniaeFusion plasmidIncN plasmidST1393

Identifiers

PMID39496788
PMCPMC11535437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.